MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
CervoMed Inc. Common Stock

CRVO

#4159
CervoMed Inc. - Common Stock
3.1 1 USD
+1.97%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.11
3.11
Year Range
2.82
13.13
Daily Change
+1.97%
Monthly Change
-17.72%
6 month change
-67.97%
Year Change
-59.24%
Previous Close
3.0 5
Open
3.1 1
Low
3.1 1
High
3.1 1
Volume
9
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CRVO
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 28.79 M
  • Employee 15
  • Founded 1995
  • CEO N/A
  • Website www.cervomed.com
  • Headquarter Delaware, United States
  • FIGI BBG000N6JH48
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.65
Price to sales ratio
17.83

News

Zacks Zacks
CRVO
2026.05.14
Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates
Zacks Zacks
CRBU CRVO
2026.05.07
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Zacks Zacks
IDYA CRVO
2026.05.05
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
Investing Investing
CRVO
2026.03.17
H.C. Wainwright reiterates CervoMed stock rating on conference data
Zacks Zacks
CRVO AGEN
2026.03.13
CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates
TipRanks TipRanks
CRVO TCRX
2026.03.05
Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com
Investing Investing
CRVO
2026.03.04
CervoMed sets 50mg dose for phase 3 dementia trial
Zacks Zacks
PHAR CRDL CRVO ABVX
2026.03.03
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?
Investing Investing
CRVO
2026.02.18
CervoMed’s neflamapimod selected for UK ALS trial platform
Investing Investing
CRVO
2025.12.18
Cantor Fitzgerald initiates CervoMed stock with Overweight rating
Investing Investing
CRVO
2025.12.04
CervoMed’s DLB drug shows promise in phase 2b trial
Investing Investing
CRVO
2025.12.04
CervoMed stock soars after promising dementia drug trial results

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd